ResearcherSecond Affiliated Hospital of Soochow UniversityActive in the last 2 years
Yecheng Li
Matched on ORCID iD 0000-0003-3578-3714; OpenAlex author ID A5103076965. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1673098↗
- YAP-LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine. Co-author DOI 10.1002/mc.23785↗
- Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. Co-author DOI 10.1038/s41419-021-04205-6↗
- Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in … Co-author DOI 10.2147/ijn.s279258↗
- The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells. First author DOI 10.2174/1871520620666200508090515↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wei Chen · 2 shared papers, 2020–2024 · strength 0.32
- Zhenyu Ye · 2 shared papers, 2020–2021 · strength 0.25
- Jinming Cao · 1 shared paper, 2025 · strength 0.25
- Mengdan Xu · 1 shared paper, 2025 · strength 0.25
- Mengyao Wu · 1 shared paper, 2025 · strength 0.25
- Dapeng Li · 1 shared paper, 2025 · strength 0.25
- Kai Chen · 1 shared paper, 2025 · strength 0.25
- Ge Li · 1 shared paper, 2025 · strength 0.25
- Shang Cai · 1 shared paper, 2021 · strength 0.13
- Wei Chen · 1 shared paper, 2021 · strength 0.13
- Yihui Sun · 1 shared paper, 2021 · strength 0.13
- Wei Li · 1 shared paper, 2020 · strength 0.12
- Wei Chen · 1 shared paper, 2020 · strength 0.12
- Chungen Xing · 1 shared paper, 2020 · strength 0.10
- Zhenyu Ye · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.